CanSino Biologics Inc. - B (09966) intends to repurchase shares worth up to HK$30 million.

Wisdom Finance APP News, CNOOC Pharmaceutical-B (09966) announced that the Board of Directors decided on November 7, 2025 not to repurchase ordinary shares from the open market from time to time, with the maximum amount of repurchased shares being 30 million Hong Kong dollars. The Board of Directors believes that the current trading price of the shares does not accurately reflect the company's intrinsic value, and also believes that this share repurchase will demonstrate the company's confidence in its business prospects and future, ultimately benefiting the company and creating value for its shareholders. The Board believes that the company's current financial resources are sufficient to support the proposed share repurchase and maintain a strong financial position.